Palonosetron Hydrochloride

盐酸帕洛诺司琼

Report date: 2026/02/14 20:00:22
NME

Base Information

Drug NamePalonosetron Hydrochloride
Drug Alias Namepalanosetron帕洛诺司琼盐酸盐Palonosetronum盐酸帕洛司琼Onicit +[16] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsChemotherapy-induced nausea and vomitingVomitingNausea +[20] 
Global Approved IndicationsChemotherapy-induced nausea and vomitingVomitingNausea
Approved Indications in ChinaChemotherapy-induced nausea and vomiting
Original Approved Country/TerritoryUnited States
Original Approved Date2003/07/25
Country/TerritoryUnited StatesUkraineRussian Federation +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesRoche Palo Alto Llc
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Fosun Pharmaceutical (Group) Co LtdEsteve Healthcare SLKnight Therapeutics +[7] 
Inactive CompaniesAbbott LaboratoriesCatalent Pharma SolutionsNational Cancer Institute +[13] 
Active IndicationsChemotherapy-induced nausea and vomiting
Inactive IndicationsVomitingNauseaPostoperative Nausea and Vomiting +[19] 

Other Information

ATC CodeA04AA05
Related LinksWikipediaDrugBankKEGG